chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: TDAP, UNK
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Reports 2 days after receiving vaccines developed hive like areas on her leg. Reports had two areas at a time. Reports every day since that time she has had two areas in different places, her abdomen, back, shoulder around her collar bone. Reports areas itch, no fluid filled or weeping areas. Reports areas go away and leave a red area. Denies any other symptoms.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Nausea, Pyrexia
Clinical narrative: Back ache, fatigue, fever, nausea
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer on 4/1 and 4/22. Positive on 9/23
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Chest pain
Clinical narrative: started having chest pain later that day
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer on 2/25 and 3/25. Positive on 9/24
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive on 9/24/21
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Infection, SARS-CoV-2 test positive
Clinical narrative: Breakthrough covid case per PCR test on 9/24/2021
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Immunodeficiency, Lymphadenopathy, Pyrexia
Clinical narrative: 3rd dose: Swollen underarm started about 24 hours after vaccine given, worsened at 48 hours,  and still lasting on 9/27 (likely swollen lympth nodes; Ibuprofen does help the pain)--Unsure how long this will last. Noticed fever at about 24 hours after vaccine given and lasted <24 hours after 3rd shot (booster given ~7 months after 2nd dose). No Nausea.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer on 3/8 and 3/29. Positive on 9/23
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Ear pain, Headache, Musculoskeletal stiffness
Clinical narrative: About an hour after the vaccine, My throat started to really hurt, nose was sneezing and coughing. I took Allegra D and Flonase. I also had a bad headache,full body aches, ear pain, and still neck. I had no fever. My symptoms continue to worsen. My nerve disorder also flared. The symptoms of my flare up includes tingling in my legs, feeling cold or very hot, creepy crawling sensations, and restless legs. I did go see the doctor (virtual md) and was initally prescribed muscle relaxer Cyclobenzaprine for my stiff neck. I then went to a 2nd doctor (in person visit) and I was prescribed Methylprednisolone, Amoxicillin, and Fluconazole. The medications are helping and I am feeling much better. I was against taking the vaccine but my employer has mandated it.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Sneezing, Urine analysis
Clinical narrative: About an hour after the vaccine, My throat started to really hurt, nose was sneezing and coughing. I took Allegra D and Flonase. I also had a bad headache,full body aches, ear pain, and still neck. I had no fever. My symptoms continue to worsen. My nerve disorder also flared. The symptoms of my flare up includes tingling in my legs, feeling cold or very hot, creepy crawling sensations, and restless legs. I did go see the doctor (virtual md) and was initally prescribed muscle relaxer Cyclobenzaprine for my stiff neck. I then went to a 2nd doctor (in person visit) and I was prescribed Methylprednisolone, Amoxicillin, and Fluconazole. The medications are helping and I am feeling much better. I was against taking the vaccine but my employer has mandated it.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Broke out in hives one day following 2nd injection of Moderna. Hives started on neck and chest and continue to move upwards towards my right and left side of neck, and down the right side of my arm (side the injection was given).
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Left arm as warm red area around injection site
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Janssen on 3/9. Positive on 9/23
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use, Product administered to patient of inappropriate age
Clinical narrative: pt inadvertently given Moderna even though Moderna is not approved for ages 12 and over. Moderna company contacted, patient is not at and increased risk of side effects or adverse events. Per their information emailed to nurse: "If given at age 12 to 17 years as the first dose, may administer the second vaccine dose 28 days later even though it is considered off-label use."
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for COVID 9/25/21
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Chills, Injected limb mobility decreased, Injection site pain, Nausea
Clinical narrative: Later the night of the 25th of September, started feeling pain from the injection site all the way down to the bottom of the wrist. Could not move the arm with help with the Right arm. The pain was sever. Got nauseas and had chills and believes to have had a fever but isn't sure.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: CSF protein increased, Diplopia, Eye disorder, Headache, Lumbar puncture abnormal
Clinical narrative: Patient presented to clinic at approximately 0615 the morning of 17 September 2021 complaining of diplopia in both eyes. Denied any headache, vertigo, nausea, vomiting, or pain associated with diplopia. Physical exam findings were unremarkable and patient was observed for approximately one hour before being released with return precautions and artificial tears for comfort. Patient returned to clinic approximately 4 hours later complaining of increased frequency of diplopia without any associated systems. Provider boarded patient on facilities Patient Care Unit for observation. Patient had no further complaints until the afternoon of 19 September where he began to complain that his diplopia was now constant with associated headache and vertigo. Patient transported to local hospital and was admitted for observation. Subsequent MRI on 20 September was negative for any abnormalities but patient began to lose Ocular Motor function later that day. Spinal tap on 23 September showed elevated protein levels in CSF and a subsequent diagnosis of Miller Fisher Syndrome was given. He was started on IgG therapy and currently remains at the inpatient unit with an anticipated discharge date of 28 September.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Miller Fisher syndrome, Vertigo
Clinical narrative: Patient presented to clinic at approximately 0615 the morning of 17 September 2021 complaining of diplopia in both eyes. Denied any headache, vertigo, nausea, vomiting, or pain associated with diplopia. Physical exam findings were unremarkable and patient was observed for approximately one hour before being released with return precautions and artificial tears for comfort. Patient returned to clinic approximately 4 hours later complaining of increased frequency of diplopia without any associated systems. Provider boarded patient on facilities Patient Care Unit for observation. Patient had no further complaints until the afternoon of 19 September where he began to complain that his diplopia was now constant with associated headache and vertigo. Patient transported to local hospital and was admitted for observation. Subsequent MRI on 20 September was negative for any abnormalities but patient began to lose Ocular Motor function later that day. Spinal tap on 23 September showed elevated protein levels in CSF and a subsequent diagnosis of Miller Fisher Syndrome was given. He was started on IgG therapy and currently remains at the inpatient unit with an anticipated discharge date of 28 September.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, COVID-19, Chest X-ray abnormal, Dyspnoea, Pneumonia
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/5/2021: Shortness of breath/difficulty breathing. Hospitalized 9/5/2021-9/6/2021. Patient was admitted to the hospital the same day of testing positive at the facility. He was discharged the next day on 9/6 but then re-admitted the same day with bilateral pulmonary embolism. At time of hospitalization, noted to have pneumonia, abnormal chest x-ray, and acute respiratory distress.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/5/2021: Shortness of breath/difficulty breathing. Hospitalized 9/5/2021-9/6/2021. Patient was admitted to the hospital the same day of testing positive at the facility. He was discharged the next day on 9/6 but then re-admitted the same day with bilateral pulmonary embolism. At time of hospitalization, noted to have pneumonia, abnormal chest x-ray, and acute respiratory distress.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Syncope
Clinical narrative: Fever, body aches, chills, headache, and fainted
Age: 23.0
Sex: M
Vaccine: MMR
Symptoms: Measles, Polymerase chain reaction positive, Rash
Clinical narrative: This is a refugee.  He developed a rash throughout his body that developed the day after the vaccination.  He was sent to the ED for evaluation and was diagnosed clinically with Measles.  PCR testing was completed and was PCR positive.  Sample was sent to CDC that confirmed PCR positive was from the vaccine.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Chest pain
Clinical narrative: Extremely sharp heart t and chest pain - lasted 30 minutes about 4-5 hours after first dose
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID(+) 9/22/21
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Death, Dyspnoea, Hypoxia
Clinical narrative: MODERNA COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/2/2021 and 1/30/2021. Patient previously hospitalized for for COVID pneumonia 8/26/2021 to 8/31/2021. Patient presented to ED on 9/9/2021 for shortness of breath. Patient was placed on BiPAP for worsening hypoxia. Patient received: methylprednisolone, zosyn, and vancomycin. Respiratory condition worsened and family decided to place patient on comfort care. Patient expired shortly after at 0953 on 9/16/2021.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lung infiltration, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: MODERNA COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/2/2021 and 1/30/2021. Patient previously hospitalized for for COVID pneumonia 8/26/2021 to 8/31/2021. Patient presented to ED on 9/9/2021 for shortness of breath. Patient was placed on BiPAP for worsening hypoxia. Patient received: methylprednisolone, zosyn, and vancomycin. Respiratory condition worsened and family decided to place patient on comfort care. Patient expired shortly after at 0953 on 9/16/2021.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Autoimmune disorder, Blood test, Polymyalgia rheumatica
Clinical narrative: autoimmune disease PMR
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: fatigue, low grade temp, body aches
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia
Clinical narrative: Patient had COVID vaccine on 3/12/21(Janssen), and is hospitalized now (admitted 9/26/21) with acute hypoxic rerspiratory failure secondary to COVID pneumonia (expected D/C is not for 3 or 4 more days)
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Full blood count, Hyperhidrosis
Clinical narrative: Severely swollen arm All around Armpit swollen tingling in fingers  Fever 101.5 Chills Sweats  Swelling increasing down arm over three days  Extremely red Fatigue  Arm is hot to touch
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Paraesthesia, Peripheral swelling, Pyrexia, Skin warm
Clinical narrative: Severely swollen arm All around Armpit swollen tingling in fingers  Fever 101.5 Chills Sweats  Swelling increasing down arm over three days  Extremely red Fatigue  Arm is hot to touch
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aspiration, COVID-19, Chest X-ray abnormal, Death, Delirium
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/13/2021 and 2/3/2021. Patient presented to ED on 9/16/2021 for hypoxia. Patient was hospitalized, became delirious, and aspirated. Patient received dexamethasone, remdesivir, ceftriaxone, and zosyn. Patient continued to decline throughout hospitalization. Family decided to transition to comfort care and patient expired at 1212 on 9/21/2021.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Lung opacity, SARS-CoV-2 test positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/13/2021 and 2/3/2021. Patient presented to ED on 9/16/2021 for hypoxia. Patient was hospitalized, became delirious, and aspirated. Patient received dexamethasone, remdesivir, ceftriaxone, and zosyn. Patient continued to decline throughout hospitalization. Family decided to transition to comfort care and patient expired at 1212 on 9/21/2021.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis chronic, Chest X-ray, Cough
Clinical narrative: Chronic cough, doctor diagnosed me with chronic bronchitis.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, Facial asymmetry, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/10/2021 and 4/7/2021. Presented to ED on 9/4/2021 with new onset of altered mental status, and right sided facial asymmetry. Patient admitted, and diagnosed as COVID-19 positive, treated with remdesivir, dexamethasone, baricitinib. Patient began requiring oxygen (3L NC) on 9/6, escalating to 5 L NC on 9/7, to 9L on 9/9, 11 L Oximizer on 9/10. Patient transitioned to comfort measures on 9/11/2021. Patient expired on 9/15/2021
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Big red rashes all over body.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Illness, Mobility decreased
Clinical narrative: I was very ill after the Moderna vaccine shot #1 (and #2- appears I must make a separate report for that?); I could not get out of bed for two days.   I felt light headed, sick, headache, body aches, was exhausted.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: I was very ill after the Moderna vaccine shot #1 (and #2- appears I must make a separate report for that?); I could not get out of bed for two days.   I felt light headed, sick, headache, body aches, was exhausted.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Amblyopia, Eye pain, Eyelid ptosis, Fatigue, Headache
Clinical narrative: Leaving the store I thought my vision was a little hazy but also I was really tired so didn't think too much of it. When my husband came home from work for lunch later that day, I asked him if his vision was hazy or blurry after his second dose. He said no; so again I just brushed it off and forgot about it. Then that evening around 5:30 pm, I was feeling a little headache pulse behind my left ear and I was feeling tired. I asked my husband to take a picture of me because I wanted to see how tired I looked. It was then that I noticed my eyes were asymmetrical; one looked different with a droopy eye lid (kind of like a lazy-eye look). My vision still felt a little off so I went inside to start cooking. 20 minutes later I felt like my vision was normal and eventually went to sleep. The next day I woke up and felt like symptoms were all gone, until I remembered my right eye situation. I looked in the mirror and the right eye was still asymmetrical (droopy lid). It feels like the right eye is having to work harder. It is hard to explain but the right eye does not feel normal to me. I made an appt with an eye doctor that day and my vision checked out ok but she did diagnose ptosis of the right eyelid. Although I do see some improvement of the droopiness of the lid, it has not returned to its normal pre-shot state and the feeling I described is still there.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Ophthalmological examination, Vision blurred
Clinical narrative: Leaving the store I thought my vision was a little hazy but also I was really tired so didn't think too much of it. When my husband came home from work for lunch later that day, I asked him if his vision was hazy or blurry after his second dose. He said no; so again I just brushed it off and forgot about it. Then that evening around 5:30 pm, I was feeling a little headache pulse behind my left ear and I was feeling tired. I asked my husband to take a picture of me because I wanted to see how tired I looked. It was then that I noticed my eyes were asymmetrical; one looked different with a droopy eye lid (kind of like a lazy-eye look). My vision still felt a little off so I went inside to start cooking. 20 minutes later I felt like my vision was normal and eventually went to sleep. The next day I woke up and felt like symptoms were all gone, until I remembered my right eye situation. I looked in the mirror and the right eye was still asymmetrical (droopy lid). It feels like the right eye is having to work harder. It is hard to explain but the right eye does not feel normal to me. I made an appt with an eye doctor that day and my vision checked out ok but she did diagnose ptosis of the right eyelid. Although I do see some improvement of the droopiness of the lid, it has not returned to its normal pre-shot state and the feeling I described is still there.
Age: 79.0
Sex: F
Vaccine: FLU4
Symptoms: Swelling of eyelid
Clinical narrative: PT STATES SWOLLEN EYE LID THE MORNING AFTER VACCINATION.  SHE TOOK BENADRYL AND ICE PACK APPLIED AND SYSTEMS RESOLVED WITHIN A COUPLE OF HOURS.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Ageusia, Anosmia, COVID-19, COVID-19 pneumonia
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/1/2021: Fever, Aches, Runny Nose/Congestion, Sore Throat, Shortness of breath/difficulty breathing, Nausea/Vomiting, Loss of smell or taste, Fatigue or tiredness, Chills, Cough. Hospitalized on 9/1/2021 with pneumonia due to COVID-19 and hyperglycemia for unknown duration. Pt was admitted to the ICU for tx of Covid pneumonia and hyperglycemia and acute on chronic kidney injury. Pt was placed in the ICU on an insulin drip and fluids and oxygen. Pt does not have good control of glucose levels. Pt was not hypoxic.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Diabetes mellitus inadequate control, Dyspnoea, Fatigue
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/1/2021: Fever, Aches, Runny Nose/Congestion, Sore Throat, Shortness of breath/difficulty breathing, Nausea/Vomiting, Loss of smell or taste, Fatigue or tiredness, Chills, Cough. Hospitalized on 9/1/2021 with pneumonia due to COVID-19 and hyperglycemia for unknown duration. Pt was admitted to the ICU for tx of Covid pneumonia and hyperglycemia and acute on chronic kidney injury. Pt was placed in the ICU on an insulin drip and fluids and oxygen. Pt does not have good control of glucose levels. Pt was not hypoxic.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia, Intensive care, Nasal congestion, Nausea, Oropharyngeal pain
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/1/2021: Fever, Aches, Runny Nose/Congestion, Sore Throat, Shortness of breath/difficulty breathing, Nausea/Vomiting, Loss of smell or taste, Fatigue or tiredness, Chills, Cough. Hospitalized on 9/1/2021 with pneumonia due to COVID-19 and hyperglycemia for unknown duration. Pt was admitted to the ICU for tx of Covid pneumonia and hyperglycemia and acute on chronic kidney injury. Pt was placed in the ICU on an insulin drip and fluids and oxygen. Pt does not have good control of glucose levels. Pt was not hypoxic.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/1/2021: Fever, Aches, Runny Nose/Congestion, Sore Throat, Shortness of breath/difficulty breathing, Nausea/Vomiting, Loss of smell or taste, Fatigue or tiredness, Chills, Cough. Hospitalized on 9/1/2021 with pneumonia due to COVID-19 and hyperglycemia for unknown duration. Pt was admitted to the ICU for tx of Covid pneumonia and hyperglycemia and acute on chronic kidney injury. Pt was placed in the ICU on an insulin drip and fluids and oxygen. Pt does not have good control of glucose levels. Pt was not hypoxic.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Breakthrough COVID-19 case with symptom onset 9/1/2021: Fever, Aches, Runny Nose/Congestion, Sore Throat, Shortness of breath/difficulty breathing, Nausea/Vomiting, Loss of smell or taste, Fatigue or tiredness, Chills, Cough. Hospitalized on 9/1/2021 with pneumonia due to COVID-19 and hyperglycemia for unknown duration. Pt was admitted to the ICU for tx of Covid pneumonia and hyperglycemia and acute on chronic kidney injury. Pt was placed in the ICU on an insulin drip and fluids and oxygen. Pt does not have good control of glucose levels. Pt was not hypoxic.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome, Incomplete course of vaccination
Clinical narrative: Patient admitted for Guillain-Barre syndrome. Only 1 Moderna dose recorded per registry.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Diarrhoea
Clinical narrative: Diarhea Chest feels heavy
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site discomfort, Injection site erythema, Injection site swelling
Clinical narrative: Patient presented with redness, swelling, discomfort, hot to touch, at the vaccine site. No fever. Diagnosed with cellulitis.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Fatigue, Fear, Headache
Clinical narrative: I was very ill after my second Moderna shot.  I was sick for one week with headache, body ache, cold symptoms, extreme fatigue, nausea, shortness of breath (one night), possible fever (one night).  I was scared on the second night and almost went to the ER; I should have.  But I toughed it out.  It was a scary experience.  I have anxiety now because I will most likely have to get a booster shot to keep my job.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nasopharyngitis, Nausea, Pain
Clinical narrative: I was very ill after my second Moderna shot.  I was sick for one week with headache, body ache, cold symptoms, extreme fatigue, nausea, shortness of breath (one night), possible fever (one night).  I was scared on the second night and almost went to the ER; I should have.  But I toughed it out.  It was a scary experience.  I have anxiety now because I will most likely have to get a booster shot to keep my job.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/12/2021 and 4/9/2021. Patient presented to emergency department on 8/26/21 with shortness of breath, cough, fatigue, and diarrhea, all starting 11 days prior to admission.  She was diagnosed with covid on 8/25.  She was admitted with acute respiratory failure with hypoxia due to covid 19 pneumonia.She was initially placed on airvo.  Inflammatory markers were elevated.  Her procalcitonin was elevated and she received and completed a course of Rocephin. She completed a 10-day course of Decadron and was changed to solumedrol.  She completed a course of remdesivir and baricitinib. She was subsequently started on cefepime with dense consolidation on her Xray. She was on Lovenox that was decreased to DVT prophylaxis dose.  Her echo showed normal LVEF of 55-60% with Grade II diastolic dysfunction. Her oxygen requirements increased, and she was intubated on 9/16. She was switched from solumedrol to a prednisone taper. Her Lovenox dose was changed to bariatric dose. She was continued on insulin.  Her Lovenox was switched to heparin.  She had worsening pulmonary fibrosis and developed hypoxia refractory to ventilatory support (saturations in the 60% range).  She was not deemed a candidate for CRRT.  ICU team met with family and her code status was changed to DNR/AND.  Patient's ventilation was deescalated. Patient expired at 1444 on 9/22/21.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Death, Diarrhoea, Diastolic dysfunction, Dyspnoea
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/12/2021 and 4/9/2021. Patient presented to emergency department on 8/26/21 with shortness of breath, cough, fatigue, and diarrhea, all starting 11 days prior to admission.  She was diagnosed with covid on 8/25.  She was admitted with acute respiratory failure with hypoxia due to covid 19 pneumonia.She was initially placed on airvo.  Inflammatory markers were elevated.  Her procalcitonin was elevated and she received and completed a course of Rocephin. She completed a 10-day course of Decadron and was changed to solumedrol.  She completed a course of remdesivir and baricitinib. She was subsequently started on cefepime with dense consolidation on her Xray. She was on Lovenox that was decreased to DVT prophylaxis dose.  Her echo showed normal LVEF of 55-60% with Grade II diastolic dysfunction. Her oxygen requirements increased, and she was intubated on 9/16. She was switched from solumedrol to a prednisone taper. Her Lovenox dose was changed to bariatric dose. She was continued on insulin.  Her Lovenox was switched to heparin.  She had worsening pulmonary fibrosis and developed hypoxia refractory to ventilatory support (saturations in the 60% range).  She was not deemed a candidate for CRRT.  ICU team met with family and her code status was changed to DNR/AND.  Patient's ventilation was deescalated. Patient expired at 1444 on 9/22/21.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Endotracheal intubation, Fatigue, Inflammatory marker increased, Intensive care
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/12/2021 and 4/9/2021. Patient presented to emergency department on 8/26/21 with shortness of breath, cough, fatigue, and diarrhea, all starting 11 days prior to admission.  She was diagnosed with covid on 8/25.  She was admitted with acute respiratory failure with hypoxia due to covid 19 pneumonia.She was initially placed on airvo.  Inflammatory markers were elevated.  Her procalcitonin was elevated and she received and completed a course of Rocephin. She completed a 10-day course of Decadron and was changed to solumedrol.  She completed a course of remdesivir and baricitinib. She was subsequently started on cefepime with dense consolidation on her Xray. She was on Lovenox that was decreased to DVT prophylaxis dose.  Her echo showed normal LVEF of 55-60% with Grade II diastolic dysfunction. Her oxygen requirements increased, and she was intubated on 9/16. She was switched from solumedrol to a prednisone taper. Her Lovenox dose was changed to bariatric dose. She was continued on insulin.  Her Lovenox was switched to heparin.  She had worsening pulmonary fibrosis and developed hypoxia refractory to ventilatory support (saturations in the 60% range).  She was not deemed a candidate for CRRT.  ICU team met with family and her code status was changed to DNR/AND.  Patient's ventilation was deescalated. Patient expired at 1444 on 9/22/21.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung consolidation, Mechanical ventilation, Oxygen saturation decreased, Procalcitonin increased, Pulmonary fibrosis
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/12/2021 and 4/9/2021. Patient presented to emergency department on 8/26/21 with shortness of breath, cough, fatigue, and diarrhea, all starting 11 days prior to admission.  She was diagnosed with covid on 8/25.  She was admitted with acute respiratory failure with hypoxia due to covid 19 pneumonia.She was initially placed on airvo.  Inflammatory markers were elevated.  Her procalcitonin was elevated and she received and completed a course of Rocephin. She completed a 10-day course of Decadron and was changed to solumedrol.  She completed a course of remdesivir and baricitinib. She was subsequently started on cefepime with dense consolidation on her Xray. She was on Lovenox that was decreased to DVT prophylaxis dose.  Her echo showed normal LVEF of 55-60% with Grade II diastolic dysfunction. Her oxygen requirements increased, and she was intubated on 9/16. She was switched from solumedrol to a prednisone taper. Her Lovenox dose was changed to bariatric dose. She was continued on insulin.  Her Lovenox was switched to heparin.  She had worsening pulmonary fibrosis and developed hypoxia refractory to ventilatory support (saturations in the 60% range).  She was not deemed a candidate for CRRT.  ICU team met with family and her code status was changed to DNR/AND.  Patient's ventilation was deescalated. Patient expired at 1444 on 9/22/21.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/12/2021 and 4/9/2021. Patient presented to emergency department on 8/26/21 with shortness of breath, cough, fatigue, and diarrhea, all starting 11 days prior to admission.  She was diagnosed with covid on 8/25.  She was admitted with acute respiratory failure with hypoxia due to covid 19 pneumonia.She was initially placed on airvo.  Inflammatory markers were elevated.  Her procalcitonin was elevated and she received and completed a course of Rocephin. She completed a 10-day course of Decadron and was changed to solumedrol.  She completed a course of remdesivir and baricitinib. She was subsequently started on cefepime with dense consolidation on her Xray. She was on Lovenox that was decreased to DVT prophylaxis dose.  Her echo showed normal LVEF of 55-60% with Grade II diastolic dysfunction. Her oxygen requirements increased, and she was intubated on 9/16. She was switched from solumedrol to a prednisone taper. Her Lovenox dose was changed to bariatric dose. She was continued on insulin.  Her Lovenox was switched to heparin.  She had worsening pulmonary fibrosis and developed hypoxia refractory to ventilatory support (saturations in the 60% range).  She was not deemed a candidate for CRRT.  ICU team met with family and her code status was changed to DNR/AND.  Patient's ventilation was deescalated. Patient expired at 1444 on 9/22/21.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Pyrexia
Clinical narrative: pt had fever up to 104 8 days after 3rd vaccine.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Imaging procedure, Laboratory test, Magnetic resonance imaging abnormal
Clinical narrative: Hospitalized for four days on Sept 9, starting having shortness of breath next day and ER Myocarditis and Pericarditis.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging heart, Myocarditis, Pericarditis
Clinical narrative: Hospitalized for four days on Sept 9, starting having shortness of breath next day and ER Myocarditis and Pericarditis.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Death, General physical health deterioration, Hypoxia
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient stated he received a third COVID vaccine around the 1st of September 2021 but unable to verify with documentation. Patient presented to ED on 9/9/2021 for hypoxia. Hospitalized for COVID pneumonia. Dexamethasone, levofloxacin, zosyn, vancomycin, and remdesivir were administered. Patient continued to decompensate throughout hospitalization. Patient was transitioned to comfort care on 9/20/2021 and expired at 1734 on 9/20/2021.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lung consolidation, Lymphadenopathy, SARS-CoV-2 test positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient stated he received a third COVID vaccine around the 1st of September 2021 but unable to verify with documentation. Patient presented to ED on 9/9/2021 for hypoxia. Hospitalized for COVID pneumonia. Dexamethasone, levofloxacin, zosyn, vancomycin, and remdesivir were administered. Patient continued to decompensate throughout hospitalization. Patient was transitioned to comfort care on 9/20/2021 and expired at 1734 on 9/20/2021.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Anal incontinence, Asthenia, Back pain, Dizziness, Dysphagia
Clinical narrative: 20 minutes after the vaccination begin having neck and back pains on the right side of the body.  Pens and needles feeling through out body, weakness, dizzy, nausea, unsteady walking, face and tongue mouth went numb,  Difficulty chewing and swallowing.  Shooting pain throughout of body, lost the control of bowel.  Catheter has been inserted. Unable to walk long distances, difficulty breathing.  Was diagnosed with Gullain-barre syndrome.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: 20 minutes after the vaccination begin having neck and back pains on the right side of the body.  Pens and needles feeling through out body, weakness, dizzy, nausea, unsteady walking, face and tongue mouth went numb,  Difficulty chewing and swallowing.  Shooting pain throughout of body, lost the control of bowel.  Catheter has been inserted. Unable to walk long distances, difficulty breathing.  Was diagnosed with Gullain-barre syndrome.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Mastication disorder, Mobility decreased, Nausea, Neck pain
Clinical narrative: 20 minutes after the vaccination begin having neck and back pains on the right side of the body.  Pens and needles feeling through out body, weakness, dizzy, nausea, unsteady walking, face and tongue mouth went numb,  Difficulty chewing and swallowing.  Shooting pain throughout of body, lost the control of bowel.  Catheter has been inserted. Unable to walk long distances, difficulty breathing.  Was diagnosed with Gullain-barre syndrome.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Paraesthesia
Clinical narrative: 20 minutes after the vaccination begin having neck and back pains on the right side of the body.  Pens and needles feeling through out body, weakness, dizzy, nausea, unsteady walking, face and tongue mouth went numb,  Difficulty chewing and swallowing.  Shooting pain throughout of body, lost the control of bowel.  Catheter has been inserted. Unable to walk long distances, difficulty breathing.  Was diagnosed with Gullain-barre syndrome.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood culture positive, Bronchiectasis, COVID-19, Computerised tomogram thorax abnormal
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/1/2021 and 3/5/2021. Patient presented to ED on 8/26/2021 with shortness of breath, after a diagnosis of COVID-19 the day prior.  Patient also has had nausea, diarhhea, diffuse muscle aches and fever as high as 101. UTI noted and patient was discharged from ED with Bactrim. Patient returned to ED on 8/31/2021 with complaints of fever, back pain, and O2 sats of 88% subsequently admitted with diagnosis of COVID-19, E. coli UTI, Severe sepsis with organ dysfunction. Patient started on ceftriaxone, remdesivir, and steroids. Blood cultures positive for staph epi 2/2 sets and started on vancomycin. Cultures cleared with patient placed on Vancomycin. Patient ultimately required high O2 requirement on HFNC. She showed some improvements but declined and 9/10 repeat CT chest showed: persistent infiltrates, worsened fibrotic changes and traction bronchiectasis compared to 1.5 weeks ago. She also was noted to have a positive fungitell. She eventually progressed to BiPAP. Pallitiave care was consulted and patient's MPOA, transitioned to DNR/AND on 9/15. Comfort care initiated with the assistance of palliative care physician.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Death, Diarrhoea, Dyspnoea, Escherichia infection
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/1/2021 and 3/5/2021. Patient presented to ED on 8/26/2021 with shortness of breath, after a diagnosis of COVID-19 the day prior.  Patient also has had nausea, diarhhea, diffuse muscle aches and fever as high as 101. UTI noted and patient was discharged from ED with Bactrim. Patient returned to ED on 8/31/2021 with complaints of fever, back pain, and O2 sats of 88% subsequently admitted with diagnosis of COVID-19, E. coli UTI, Severe sepsis with organ dysfunction. Patient started on ceftriaxone, remdesivir, and steroids. Blood cultures positive for staph epi 2/2 sets and started on vancomycin. Cultures cleared with patient placed on Vancomycin. Patient ultimately required high O2 requirement on HFNC. She showed some improvements but declined and 9/10 repeat CT chest showed: persistent infiltrates, worsened fibrotic changes and traction bronchiectasis compared to 1.5 weeks ago. She also was noted to have a positive fungitell. She eventually progressed to BiPAP. Pallitiave care was consulted and patient's MPOA, transitioned to DNR/AND on 9/15. Comfort care initiated with the assistance of palliative care physician.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fungal test positive, Influenza A virus test negative, Influenza B virus test, Lung infiltration, Myalgia
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/1/2021 and 3/5/2021. Patient presented to ED on 8/26/2021 with shortness of breath, after a diagnosis of COVID-19 the day prior.  Patient also has had nausea, diarhhea, diffuse muscle aches and fever as high as 101. UTI noted and patient was discharged from ED with Bactrim. Patient returned to ED on 8/31/2021 with complaints of fever, back pain, and O2 sats of 88% subsequently admitted with diagnosis of COVID-19, E. coli UTI, Severe sepsis with organ dysfunction. Patient started on ceftriaxone, remdesivir, and steroids. Blood cultures positive for staph epi 2/2 sets and started on vancomycin. Cultures cleared with patient placed on Vancomycin. Patient ultimately required high O2 requirement on HFNC. She showed some improvements but declined and 9/10 repeat CT chest showed: persistent infiltrates, worsened fibrotic changes and traction bronchiectasis compared to 1.5 weeks ago. She also was noted to have a positive fungitell. She eventually progressed to BiPAP. Pallitiave care was consulted and patient's MPOA, transitioned to DNR/AND on 9/15. Comfort care initiated with the assistance of palliative care physician.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Positive airway pressure therapy, Pulmonary fibrosis, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/1/2021 and 3/5/2021. Patient presented to ED on 8/26/2021 with shortness of breath, after a diagnosis of COVID-19 the day prior.  Patient also has had nausea, diarhhea, diffuse muscle aches and fever as high as 101. UTI noted and patient was discharged from ED with Bactrim. Patient returned to ED on 8/31/2021 with complaints of fever, back pain, and O2 sats of 88% subsequently admitted with diagnosis of COVID-19, E. coli UTI, Severe sepsis with organ dysfunction. Patient started on ceftriaxone, remdesivir, and steroids. Blood cultures positive for staph epi 2/2 sets and started on vancomycin. Cultures cleared with patient placed on Vancomycin. Patient ultimately required high O2 requirement on HFNC. She showed some improvements but declined and 9/10 repeat CT chest showed: persistent infiltrates, worsened fibrotic changes and traction bronchiectasis compared to 1.5 weeks ago. She also was noted to have a positive fungitell. She eventually progressed to BiPAP. Pallitiave care was consulted and patient's MPOA, transitioned to DNR/AND on 9/15. Comfort care initiated with the assistance of palliative care physician.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sepsis, Staphylococcal infection, Staphylococcus test positive, Urinary tract infection
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/1/2021 and 3/5/2021. Patient presented to ED on 8/26/2021 with shortness of breath, after a diagnosis of COVID-19 the day prior.  Patient also has had nausea, diarhhea, diffuse muscle aches and fever as high as 101. UTI noted and patient was discharged from ED with Bactrim. Patient returned to ED on 8/31/2021 with complaints of fever, back pain, and O2 sats of 88% subsequently admitted with diagnosis of COVID-19, E. coli UTI, Severe sepsis with organ dysfunction. Patient started on ceftriaxone, remdesivir, and steroids. Blood cultures positive for staph epi 2/2 sets and started on vancomycin. Cultures cleared with patient placed on Vancomycin. Patient ultimately required high O2 requirement on HFNC. She showed some improvements but declined and 9/10 repeat CT chest showed: persistent infiltrates, worsened fibrotic changes and traction bronchiectasis compared to 1.5 weeks ago. She also was noted to have a positive fungitell. She eventually progressed to BiPAP. Pallitiave care was consulted and patient's MPOA, transitioned to DNR/AND on 9/15. Comfort care initiated with the assistance of palliative care physician.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: Patient felt very weak as if she was going to faint. Gave patient an ice pack and called EMS to check patient out. Patient refused to be seen at the hospital and left on her own feeling better.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bella palsy.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Asthenia, Bacterial test, Blood creatinine increased, Blood lactic acid normal
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to ED with generalized weakness for several days prior to admission. Patient noticed difficulty walking and progressed to being unable to stand/get out of chair. In the ED, temp 99.9, vitals stable.  Labs with normal WBC, procalcitonin 0.51, lactate wnl, Cr 2.06, BNP 604 and trop 0.1.  UA with rare bact, 3+LE, 20-50 WBCs. Patient was admitted for acute hypoxic respiratory failure, due to covid 19. He was treated with steroids for 10 days and cefepime.  He had acute CHF, renal failure.  He eventually developed spontaneous PTX and had chest tube placed by pulmonary.  Goals of care addressed with family who eventually elected comfort measures and hospice. Patient expired at 1600 on 9/17/21.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Cardiac failure congestive, Chest tube insertion, Death
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to ED with generalized weakness for several days prior to admission. Patient noticed difficulty walking and progressed to being unable to stand/get out of chair. In the ED, temp 99.9, vitals stable.  Labs with normal WBC, procalcitonin 0.51, lactate wnl, Cr 2.06, BNP 604 and trop 0.1.  UA with rare bact, 3+LE, 20-50 WBCs. Patient was admitted for acute hypoxic respiratory failure, due to covid 19. He was treated with steroids for 10 days and cefepime.  He had acute CHF, renal failure.  He eventually developed spontaneous PTX and had chest tube placed by pulmonary.  Goals of care addressed with family who eventually elected comfort measures and hospice. Patient expired at 1600 on 9/17/21.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysstasia, Gait disturbance, Mobility decreased, Pneumothorax spontaneous, Procalcitonin
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to ED with generalized weakness for several days prior to admission. Patient noticed difficulty walking and progressed to being unable to stand/get out of chair. In the ED, temp 99.9, vitals stable.  Labs with normal WBC, procalcitonin 0.51, lactate wnl, Cr 2.06, BNP 604 and trop 0.1.  UA with rare bact, 3+LE, 20-50 WBCs. Patient was admitted for acute hypoxic respiratory failure, due to covid 19. He was treated with steroids for 10 days and cefepime.  He had acute CHF, renal failure.  He eventually developed spontaneous PTX and had chest tube placed by pulmonary.  Goals of care addressed with family who eventually elected comfort measures and hospice. Patient expired at 1600 on 9/17/21.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal failure, SARS-CoV-2 test positive, Troponin, Urine analysis abnormal, White blood cell count normal
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to ED with generalized weakness for several days prior to admission. Patient noticed difficulty walking and progressed to being unable to stand/get out of chair. In the ED, temp 99.9, vitals stable.  Labs with normal WBC, procalcitonin 0.51, lactate wnl, Cr 2.06, BNP 604 and trop 0.1.  UA with rare bact, 3+LE, 20-50 WBCs. Patient was admitted for acute hypoxic respiratory failure, due to covid 19. He was treated with steroids for 10 days and cefepime.  He had acute CHF, renal failure.  He eventually developed spontaneous PTX and had chest tube placed by pulmonary.  Goals of care addressed with family who eventually elected comfort measures and hospice. Patient expired at 1600 on 9/17/21.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cells urine positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to ED with generalized weakness for several days prior to admission. Patient noticed difficulty walking and progressed to being unable to stand/get out of chair. In the ED, temp 99.9, vitals stable.  Labs with normal WBC, procalcitonin 0.51, lactate wnl, Cr 2.06, BNP 604 and trop 0.1.  UA with rare bact, 3+LE, 20-50 WBCs. Patient was admitted for acute hypoxic respiratory failure, due to covid 19. He was treated with steroids for 10 days and cefepime.  He had acute CHF, renal failure.  He eventually developed spontaneous PTX and had chest tube placed by pulmonary.  Goals of care addressed with family who eventually elected comfort measures and hospice. Patient expired at 1600 on 9/17/21.